Evidence map›Paper›PMID 29988943›Full record

ArticleRadiology case reports2018

Giant retroperitoneal schwannoma in a 52-year-old man.

Taiyou L Harada, Go Nagao, Teiichiro Aoyagi, Isao Kuroda, Naoto Tokuyama, Masahide Takahashi, Yuri Takahashi, Yukio Morishita, Sugahara Shinji

Open access · goldAbstract readCase Reports
In one paragraph

Article in Radiology case reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Retroperitoneal shwannoma: A case report.Annals of medicine and surgery (2012) · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Taiyou L HaradaDepartment of Radiology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan.
Go NagaoDepartment of Urology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan.
Teiichiro AoyagiDepartment of Urology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan.
Isao KurodaDepartment of Urology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan.
Naoto TokuyamaDepartment of Urology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan.
Masahide TakahashiDepartment of Radiology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan.
Yuri TakahashiDepartment of Radiology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan.
Yukio MorishitaDepartment of Pathology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan.
Sugahara ShinjiDepartment of Radiology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan.
Tokyo Medical University Ibaraki Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schwannoma in the retroperitoneal space is rare, and it is extremely rare in patients with no history of neurofibromatosis. We present a case of giant retroperitoneal schwannoma in a 52-year-old man who did not have neurofibromatosis. Because malignant transformation would be extremely rare in this circumstance, close imaging follow-up could avert the necessity for complete resection. The possibility of schwannoma should be considered when evaluating retroperitoneal tumors with the characteristic findings, even if there is no connection between the tumor and the intervertebral foramina.

Indexed as

CTMalignancyMRIOpen biopsyRetroperitoneal tumorSchwannoma

Identifiers

PMID29988943
PMCPMC6034139
OpenAlexW2805835927

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.